semaglutide coming off shortage list FDA: Novo Nordisk's Ozempic and Wegovy, long in shortage, now available Federal judge upholds FDA's removal

Although improved insulin sensitivity was an outcome of this study, this cannot be generalized to a human population due to the use of mice, as well as the lack of whole-body insulin sensitivity measures

The incidence of diabetes insipidus with the conventional dose was 52%, intermediate dose, 36% and low dose, 24% (p = 0.025)

The failed trial adds to mounting challenges for Novo Nordisk stock this year as shares have tumbled more than 50% in 2025, while losing two-thirds of their value over the past 18 months

Magnesium and chromium contribute to efficient glucose uptake and energy use in working muscle

Schwannomas are more frequently encapsulated by epineurium than neurofibromas and malignant PNSTs